For the Inventor, By the Inventor

Enter assignee name

Roseville, MN, United States of America

Rebiotix, Inc.

USPTO Granted Patents = 34

EPO Patents = 4

Trademarks = 4

Forward Citations = 362

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Lee A Jones (28 out of 29 patents)

Courtney R Jones (28 out of 28 patents)

Edwin J Hlavka (22 out of 84 patents)

4. Ryan D Gordon (16 out of 17 patents)

5. Beth Anne-Szkudlarek Brown (10 out of 14 patents)

6. Joshua Erickson (10 out of 13 patents)

7. Messac Che Neba (3 out of 3 patents)

8. Mary Kay Sobcinski (2 out of 2 patents)

34 patents: Sort by Forward Citations

1. 12102655 - Bacteriotherapy for clostridium difficile colitis (2024-10-01),

2. 12083150 - Microbiota restoration therapy (MRT), composition and methods of manufacture (2024-09-10),

3. 12036250 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2024-07-16),

4. 11986500 - Bacteriotherapy for clostridium difficile colitis (2024-05-21),

5. 11944654 - Bacteriotherapy for clostridium difficile colitis (2024-04-02),

6. 11654164 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2023-05-23),

7. 11642381 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2023-05-09),

8. 11554143 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2023-01-17),

9. 11446337 - Bacteriotherapy for clostridium difficile colitis (2022-09-20),

10. 10905726 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2021-02-02),

11. 10828340 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2020-11-10),

12. 10799539 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2020-10-13),

13. 10688137 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2020-06-23),

14. 10624932 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2020-04-21),

15. 10610547 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2020-04-07),

Rebiotix, Inc. is a biotechnology company specializing in microbiome-based therapeutics. They develop innovative treatments that harness the power of the human microbiome to restore health and improve outcomes for patients. Through their proprietary Microbiota Restoration Therapy platform, they aim to bring pioneering solutions to patients with gastrointestinal diseases by delivering live, human-derived microbes that can replenish the patient's disrupted microbiome. Their therapies are based on extensive research and clinical trials, and they offer new possibilities for restoring and maintaining a balanced microbiome.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

34 Patents

#6 in Roseville, MN

#284 in Minnesota

#9,984 in US

#19,575 in the World

Roseville, MN, United States of America

Rebiotix, Inc.

Forward Citations = 362

8 inventors:

Lee A Jones (28 out of 29 patents)

Courtney R Jones (28 out of 28 patents)

Edwin J Hlavka (22 out of 84 patents)

4. Ryan D Gordon (16 out of 17 patents)

5. Beth Anne-Szkudlarek Brown (10 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…